KERALA AYURVEDA
Back to Cashflow Statement
|
KERALA AYURVEDA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-9.48 Cr | ₹18 Cr | ₹-1.14 Cr | ₹-13 Cr | ₹6.20 Cr |
What is the latest Cash Flow from Financing Activities ratio of KERALA AYURVEDA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-9.48 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-1.14 Cr |
| Mar2022 | ₹-13 Cr |
| Mar2021 | ₹6.20 Cr |
How is Cash Flow from Financing Activities of KERALA AYURVEDA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.48 Cr | Negative | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-1.14 Cr | Negative | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹6.20 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹338.1 Cr | -6.3% | -10.7% | -34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -6.3% |
-10.7% |
-34.1% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses